2023 RNS Biosimilar Dinner Series

Accredited Education / Complimentary Dinner / Networking Opportunities

Accredited Education
Complimentary Dinner
Networking Opportunities

Dinner is on us!

Join us for this free, live, in-person, accredited dinner event.

Find a Program Near You!

Jacqueline Fritz, MSN, RN‑BC

Rheumatology Nurse Practitioner
AO Med

Kamrin Macki, RN, BSN, MS, NP‑C

Gastroenterology/Hepatology Nurse Practitioner
Altru Health Systems

Karen McKerihan, MSN, NP‑C

Director of Infusion Services
Articularis Healthcare

Activity Description:

With a new wave of biosimilars poised to hit the marketplace in 2023, it is crucial for providers to stay up-to-date on key concepts related to biosimilars such as drug interchangeability, substitution, and the nocebo effect. This educational dinner activity will provide attendees with a solid understanding of the vocabulary of biosimilars, the biosimilar approval process, and the clinical evidence supporting biosimilar use. Attendees will also have a chance to hear from faculty experts on ways to address common and/or confusing patient questions about biosimilars so they will feel more confident in their ability to handle these hard questions on a day-to-day basis.

Don't miss out on this opportunity to expand your knowledge and connect with colleagues in your field. Register today for dinner in a city near you!

Attendees will have the opportunity to receive 1.5 nursing contact hours for their attendance.

Program Details

Target Audience

The target audience for this initiative includes registered nurses (RNs), nurse practitioners (NPs), physician assistants (PAs), licensed practical and vocational nurses (LPNs/LVNs), and other healthcare professionals who are engaged in clinical practice, education, research, and advocacy for the care of adult and pediatric patients with rheumatic or gastroenterologic diseases. The content of this education will also be applicable to healthcare professionals new to rheumatology or gastroenterology, as well as students considering entering either of these specialties.
Learning Objective & Goals
1. Describe how a biosimilar differs from a reference biologic, as well as a traditional generic product
2. Define key concepts related to biosimilars such as drug interchangeability, substitution, and the nocebo effect
3. Analyze current barriers to the use of biosimilars in clinical practice
4. Address common and challenging patient questions surrounding the use of biosimilars in clinical practice
Evaluation Process
Disclosures

According to the disclosure policy of RNS, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.

Planners, reviewers, and faculty have disclosed no conflicts of interest related to the content of this education with the exception of the following:

Karen McKerihan - Advisory Board: Janssen, Novartis, Pfizer, Fresenius Kabi

Jacqueline Fritz, MSN, RN-BC - Speakers Bureau: AbbVie, Horizon

Off-label Product Disclosure: This activity will review off-label or investigational information of the following: AVT02, CT-P17

Educational Support: This activity has been supported by an unrestricted educational grant from Pfizer and Sandoz Inc., a Novartis Division. The complimentary dinner is provided by the Rheumatology Nurses Society.

Accreditation Statement

The Rheumatology Nurses Society is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500).

Participants will receive 1.5 hours of continuing nursing contact hours, with 1.5 pharmacotherapeutic hours, by attending and participating in the educational event, completing an online evaluation, and completing a posttest.